CompletedPhase 2

Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy

Germany13 participantsStarted 2008-10

Plain-language summary

This study will evaluate the efficacy of BGG492 in reducing the sensitivity to flashing lights of patients with photosensitive epilepsy, using EEG as a readout.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosis of photosensitive epilepsy Exclusion Criteria: \- inconsistent photoparoxysmal response when stimulated by photic stimulation Other protocol-defined inclusion/exclusion criteria may apply.

What they're measuring

Outcome Measure: Photoparoxysmal response (PPR) and standardized photoparoxysmal response (SPR) determined by EEG on all treatment days.

Timeframe: Days 1, 2 and 3

Trial details

NCT IDNCT00784212

SponsorNovartis Pharmaceuticals

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2010-09

View on ClinicalTrials.gov More Photosensitive Epilepsy trials